Atlas Trials

Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis

Clinical trial NCT01998503 · COMPLETED

Trial details

NCT number
NCT01998503
Sponsor
Nanjing University School of Medicine
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Amyloidosis
Start date
2007-12-01
Primary completion
2013-06-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.